NCT03760237Completed
Cardiovascular Function in Acute Leukemia
Cardiovascular Function in Leukemia Patients: an Observational Prospective Study
Source: ClinicalTrials.gov · Last updated 10 Oct 2024
Brief summary (registry, in English)
An observational, prospective study to describe the rates and predictors of cardiovascular events in patients with acute leukemia.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 84 (actual)
- First submitted
- 29 Nov 2018
- Start date
- 10 Dec 2018
- Primary completion date
- 6 May 2024
- Lead sponsor
- Abramson Cancer Center at Penn Medicine
- NCT number
- NCT03760237
What you commit to
- Study type: Observational
- Participants enrolled: 84
- From 10 Dec 2018 to the primary completion date, 6 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable to provide informed consent
Who the study is looking for
- Older than 18 years of age,
- New diagnosis of untreated acute leukemia (prior treatment for myelodysplastic syndrome or myeloproliferative neoplams or prior treatment with an anthracycline for breast cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma or another diagnosis will be included).
- Signed the informed consent form
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.